Goldman Sachs Group Inc T2 Biosystems, Inc. Transaction History

Goldman Sachs Group Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 May 14, 2024	BUY	$0.09 - $565.0 $8 - $55,370	98 Added 0.04%	226,905 $25,000
Q3 2022 Nov 10, 2022	BUY	$0.09 - $565.0 $8 - $55,370	98 Added 0.04%	226,905 $0
Q2 2022 May 14, 2024	BUY	$0.15 - $0.54 $34,021 - $122,475	226,807 New	226,807 $37,000
Q2 2022 Aug 15, 2022	BUY	$0.15 - $0.54 $0 - $1	2 Added 0.0%	226,807 $37,000
Q1 2022 May 16, 2022	SELL	$0.36 - $0.57 $587,534 - $930,262	-1,632,040 Reduced 87.8%	226,805 $119,000
Q4 2021 Feb 14, 2022	SELL	$0.46 - $0.94 $1.15 Million - $2.35 Million	-2,499,980 Reduced 57.35%	1,858,845 $960,000
Q3 2021 Nov 10, 2021	BUY	$0.86 - $1.21 $3.75 Million - $5.27 Million	4,358,825 New	4,358,825 $3.99 Million

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $15.9M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.